Securities code: 002755 securities abbreviation: Beijing Aosaikang Pharmaceutical Co.Ltd(002755) Announcement No.: 2022-008
Beijing Aosaikang Pharmaceutical Co.Ltd(002755)
Notice on convening the first extraordinary general meeting of shareholders in 2022
The company and all members of the board of directors guarantee that the information disclosed is true, accurate and complete without false records, misleading statements or major omissions.
Beijing Aosaikang Pharmaceutical Co.Ltd(002755) (hereinafter referred to as “the company”) deliberated and adopted the proposal on convening the company’s first extraordinary general meeting in 2022 at the 18th meeting of the Fifth Board of directors. The relevant matters of the first extraordinary general meeting in 2022 are hereby notified as follows:
1、 Basic information of the meeting
1. Session of the general meeting of shareholders: the first extraordinary general meeting of shareholders in 2022.
2. Convener of the general meeting of shareholders: the board of directors of the company.
3. Legality and compliance of the meeting: the convening of the general meeting of shareholders complies with the provisions of the company law, the rules for the general meeting of shareholders of listed companies and other relevant laws and regulations, departmental rules, normative documents and the articles of association.
4. Date and time of the meeting:
(1) On site meeting time: 14:30, February 18, 2022 (Friday)
(2) Online voting time: February 18, 2022
Among them, the specific time of online voting through the trading system of Shenzhen stock exchange is: 9:15-9:25, 9:30-11:30 and 13:00-15:00 on February 18, 2022; The specific time for voting through the Internet voting system of Shenzhen stock exchange is any time from 9:15 to 15:00 on February 18, 2022.
5. Meeting mode: this meeting adopts the combination of on-site voting and online voting.
The company will use the trading system and Internet voting system of Shenzhen Stock Exchange（ http://wltp.cn.info.com.cn. ）Provide the shareholders of the company with a voting platform in the form of network, and the shareholders can exercise their voting rights through the above system during the online voting time.
Way of attending the general meeting of shareholders: shareholders of the company can only choose one of on-site voting, voting in the trading system of Shenzhen Stock Exchange and voting in the Internet system of Shenzhen Stock Exchange. In case of repeated voting of the same voting right, the first valid voting result shall prevail.
6. Equity registration date: Monday, February 14, 2022.
7. Meeting attendees
(1) At 15:00 p.m. on February 14, 2022, when the stock market closes, the shareholders of the company registered in Shenzhen Branch of China Securities Depository and Clearing Co., Ltd. have the right to attend and vote at the general meeting of shareholders in the form of announcement of this notice; Shareholders who cannot attend the on-site meeting in person may authorize others to attend on their behalf (the authorized person does not need to be a shareholder of the company, and the power of attorney is attached), or participate in online voting during online voting time;
(2) Directors, supervisors, senior managers and other relevant personnel of the company;
(3) A lawyer employed by the company.
8. Venue: conference room 1, 5th floor, Huifeng Hotel, Jiangning, Nanjing.
2、 Matters considered at the meeting
1、 Proposal Name: No. proposal name 1.00 on the general election of the board of directors and nomination of members of the sixth board of directors of the company (non independent directors) 1.01 elect Mr. Chen Qingcai as a non independent director of the sixth board of directors 1.02 elect Ms. Wang Xiaowen as a non independent director of the sixth board of directors 1.03 elect Ms. Zhou suling as a non independent director of the sixth board of directors 1.04 elect Mr. Ma Jingfei as a non independent director of the sixth board of directors 1.05 elect Mr. Xu Youyin as a non independent director of the sixth board of directors of the company Independent directors 1.06 elect Mr. Chen Xiangfeng as a non independent director of the sixth board of directors 2.00 about the general election of the board of directors and nomination of members of the sixth board of directors (independent directors) Proposal 2.01 election of Mr. Wu Xiaoming as an independent director of the sixth board of directors 2.02 election of Mr. Li Di as an independent director of the sixth board of directors 2.03 election of Mr. Liu Jianwen as an independent director of the sixth board of directors 3.00 proposal on general election of the board of supervisors and nomination of non employee representative supervisors of the sixth board of supervisors of the company
2. Disclosure of the proposal:
The above proposals have been deliberated and adopted at the 18th meeting of the 5th board of directors and the 17th meeting of the 5th board of supervisors. For details, please refer to the securities times, securities daily and cninfo.com published on the same day（ http://www.cn.info.com.cn. ）Company announcements on.
3. Special emphasis:
(1) The above proposals 1-3 belong to ordinary voting matters and shall be adopted by more than half of the voting rights held by the shareholders (including agents) attending the general meeting of shareholders; The qualification and independence of independent director candidates shall be filed and reviewed by Shenzhen Stock Exchange, and the shareholders’ meeting can vote only after there is no objection.
(2) The above proposals 1-2 are elected by cumulative voting system: 6 non independent directors and 3 independent directors should be elected. The number of voting votes owned by shareholders shall be the number of voting shares held by them multiplied by the number of candidates to be elected. Shareholders may arbitrarily distribute the number of voting votes among candidates within the limit of the number of candidates to be elected (they may cast zero votes), but the total number shall not exceed the number of voting votes they have.
(3) In the above proposal, for major matters affecting the interests of small and medium-sized investors (small and medium-sized investors refer to other shareholders except directors, supervisors, senior managers and shareholders who individually or jointly hold more than 5% of the shares of the company), the votes of small and medium-sized investors will be counted separately, and the results of the separate vote counting will be disclosed in a timely manner.
3、 Proposal code
remarks
Proposal code proposal name the ticked column can vote
100 total proposals: all proposals except cumulative voting proposals √
Cumulative voting proposal
1.00 proposal on the general election of the board of directors and the nomination of members of the sixth board of directors of the company (not only 6 legislative directors)
1.01 elect Mr. Chen Qingcai as a non independent director of the sixth board of directors √
1.02 elect Ms. Wang Xiaowen as a non independent director of the sixth board of directors √
1.03 elect Ms. Zhou suling as a non independent director of the sixth board of directors √
1.04 elect Mr. Ma Jingfei as a non independent director of the sixth board of directors √
1.05 elect Mr. Xu Youyin as a non independent director of the sixth board of directors √
1.06 elect Mr. Chen Xiangfeng as a non independent director of the sixth board of directors √
2.00 proposal on general election of the board of directors and nomination of members of the sixth board of directors of the company (3 independent directors)
2.01 elect Mr. Wu Xiaoming as an independent director of the sixth board of directors √
2.02 elect Mr. Li Di as an independent director of the sixth board of directors of the company √
2.03 elect Mr. Liu Jianwen as the independent director of the sixth board of directors √
Non cumulative voting proposal
3.00 general election of the board of supervisors and nomination of non employee representatives of the sixth board of supervisors √
Proposal of the supervisor
4、 Meeting registration and other matters
1. Registration method: on-site registration, registration by letter or fax
2. Registration time: February 17, 2022 (9:00-11:30 and 13:30-16:30)
3. Registration place: Securities Affairs Department, building a, No. 699 Kejian Road, Jiangning Science Park, Nanjing
4. Registration method:
(1) Natural person shareholders shall register with their ID card and shareholder account card (fill in Annex III); (2) Corporate shareholders shall register with a copy of business license (with official seal), power of attorney of legal representative, shareholder account card and ID card of attendees; If the legal representative of the legal person shareholder attends in person, he / she shall register with his / her ID card, copy of business license (with official seal), certificate of legal representative and shareholder account card (fill in Annex III);
(3) The entrusted agent shall register with his ID card, power of attorney, ID card of the principal and shareholder account card (fill in Annex II);
(4) Non local shareholders can register by written letter, e-mail or fax with the above relevant certificates; The deadline for registration by written letter, e-mail or fax to the Securities Affairs Department of the company is 16:30 on February 17, 2022;
(5) Telephone registration is not accepted.
(6) Address for delivery of written letter: Securities Affairs Department, building a, No. 699, Kejian Road, Jiangning Science Park, Nanjing. Please indicate ” Beijing Aosaikang Pharmaceutical Co.Ltd(002755) the first extraordinary general meeting of shareholders in 2022″ on the letter.
Postal Code: 211112
Tel: 025-52292222
Fax: 025-52169333
Contact email: ir@ask -pharm. com.
5、 Specific operation process of participating in online voting
At this shareholders’ meeting, shareholders of the company can vote through the trading system of Shenzhen Stock Exchange or the Internet voting system（ http://wltp.cn.info.com.cn. ）See Annex I for the specific operation process of online voting.
6、 Other matters
1. The duration of the meeting is half a day, and the shareholders attending the meeting shall bear their own accommodation and transportation expenses.
2. Meeting contact information
Contact person: Ren Caixia
Tel: 025-52292222
Fax: 025-52169333
Contact email: ir@ask -pharm. com.
Contact address: Securities Affairs Department, building a, No. 699, Kejian Road, Jiangning Science Park, Nanjing
Postal Code: 211112
3. Please arrive at the venue 10 minutes in advance.
7、 Documents for future reference
1. Resolution of the 18th meeting of the 5th board of directors;
2. Independent opinions of independent directors on matters related to the 18th meeting of the Fifth Board of directors of the company; 3. Resolution of the 17th meeting of the 5th board of supervisors;
8、 Attachment
1. Annex I: specific operation process of participating in online voting
2. Annex II: power of attorney
3. Annex III: registration form of shareholders’ Participation
Beijing Aosaikang Pharmaceutical Co.Ltd(002755) board of directors January 21, 2022
Annex I:
Specific operation process of participating in online voting
1、 Online voting program
1. Voting code: 362755
2. Voting abbreviation: “Saikang voting”
3. Fill in voting opinions:
For the non cumulative voting proposal of the general meeting of shareholders, fill in the voting opinions: agree, disagree and abstain. For cumulative voting proposals, fill in the number of election votes cast for a candidate. The shareholders of the company shall vote within the limit of the number of electoral votes of each proposal group they have. If the number of electoral votes cast by shareholders exceeds the number of electoral votes they have, their electoral votes for the proposal group shall be deemed invalid. If you do not agree with a candidate, you can vote 0 for the candidate.
List of election votes for candidates under cumulative voting system
Fill in the number of election votes cast for candidates
Vote X1 for candidate a
Vote x2 for candidate B
… …
The total shall not exceed the number of election votes owned by the shareholder
The number of voting votes held by shareholders under each proposal group is as follows:
Election of non independent directors (for example, proposal 1, equal election shall be adopted, and the number of candidates shall be 6)
The number of voting votes held by shareholders = the total number of voting shares represented by shareholders × six
Shareholders may distribute their voting votes among the six independent director candidates at will, but the total number of votes shall not exceed their voting votes.
3. When shareholders vote on the general proposal, they are deemed to have the same expression on all proposals except the cumulative voting proposal
